Please login to the form below

Not currently logged in
Email:
Password:

Stiefel

This page shows the latest Stiefel news and features for those working in and with pharma, biotech and healthcare.

Langland and CAHG take top prizes at Best of Health Awards

Langland and CAHG take top prizes at Best of Health Awards

Healthcare Professional - Digital Media. 'Behind the Façade' for Stiefel, by DJM Unlimited Richmond .

Latest news

  • GSK unit takes new ofatumumab formulation into phase III GSK unit takes new ofatumumab formulation into phase III

    GlaxoSmithKline's dermatology unit Stiefel has started a phase III trial of ofatumumab in a rare and life-threatening autoimmune disorder of the skin.

  • Alkermes cuts jobs in Ireland as Novartis invests Alkermes cuts jobs in Ireland as Novartis invests

    GSK also elected not to close a plant in Sligo operated by its Stiefel subsidiary.

  • GSK reverses closure of Irish manufacturing facility GSK reverses closure of Irish manufacturing facility

    GSK reverses closure of Irish manufacturing facility. But will initially cut staff numbers at Stiefel's Sligo plant by a third. ... Looking to the future, Sligo will play an important role in our Stiefel consumer business.”.

  • Pharma deals for June 2012 Pharma deals for June 2012

    Under the agreement, Stiefel will assume responsibility for the further development, manufacturing, commercialisation, and worldwide distribution. ... Basilea/ Stiefel Labs (GSK). Acquisition. Toctino (alitretinoin), oral retinoid for severe chronic hand

  • GSK signs eczema drug deal with Basilea GSK signs eczema drug deal with Basilea

    As part of the deal, Stiefel will acquire all rights to Toctino and will license certain clinical information from Basilea. ... Stiefel would in turn be responsible for the product's further development, manufacture and commercialisation worldwide.

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest appointments

  • David Kendall joins Alimentary Health David Kendall joins Alimentary Health

    Kendall brings to the role over 25 years of commercial experience, having held positions at Chefaro Pharmaceuticals, GlaxoSmithKline, Quest Vitamins and Stiefel Laboratories.

  • Michael Le Brocq joins Langland Michael Le Brocq joins Langland

    Joining from ICC Lowe London, where he was head of strategy, Le Brocq has held senior pharmaceutical marketing roles at Parke-Davis (Pfizer), Novartis and Stiefel.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics